MaxCyte's technology will support TG Therapeutics' efforts to develop a CD19 CAR T cell therapy program for autoimmune diseases.
Axplora operates nine API manufacturing sites across Europe and India, with the goal of providing multi-site capacity to ...
A bioprocessing research and training institute in Ireland has successfully tested two new techniques for noninvasive monitoring of cell viability.
In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...
The versatility of biological products to treat disease never before considered has led numerous biopharmaceutical companies recently to announce expansions of production bioreactor capacity in the ...
Nanoneedle technology offers the capability to simultaneously quantify titers of true, full viral genomes and a range of partial species.
Boehringer will leverage ExpressionEdits' Genetic Syntax Engine which generates optimized introns to increase protein expression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback